Pancreatic Cancer Research

ResearcherPeking University Third HospitalActive in the last 2 years

Junjie Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1388-076X; OpenAlex author ID A5100395790. Sources: ClinicalTrials.gov.

Their work

Papers
1 (first author 0, last author 1)
Trials
3 (principal investigator on 3)
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2020: 1 trial · 2021: none · 2022: 1 paper · 2023: 1 trial · 2024: 1 trial

Papers 1

  1. Efficacy and safety of 3D printing coplanar template-assisted iodine-125 seed implantation as palliative treatment for inoperable pancreatic cancer. Last author DOI 10.5114/jcb.2022.114990↗

Trials 3

  1. SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer Principal investigator NCT06422156↗
  2. SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study) Principal investigator NCT06009029↗
  3. Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer Principal investigator NCT06195254↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Baohu Wang · 1 shared paper, 2022 · strength 0.16
  2. Ruoyu Wang · 1 shared paper, 2022 · strength 0.16
  3. Bin Qiu · 1 shared paper, 2022 · strength 0.16
  4. Linlin Wu · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.